• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC INCORPORATED TIGRIS INSTRUMENT SYS-CD; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC INCORPORATED TIGRIS INSTRUMENT SYS-CD; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 105118
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/02/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, hologic received a report of customer getting two failed aptima trichomonas vaginalis (atv) runs on the tigris instrument to hologic technical support (ts).In addition, the customer noted multiple equivocal results in the aptima combo 2 (ac2) assay on the same instrument.Hologic requested additional logs from the customer for review.The data showed seven valid worklist where results may have been impacted by the "spiking" in the curves.The seven worklists contain ac2, (b)(6) and atv assay results.Customer was notified of the issue.Customer indicated that all valid results were reported out.Field service engineer determined the auto detect (ad) injector caused the issue.Fse repaired the instrument.Customer later reported that all of the potentially affected samples were retested and results were amended.Per risk assessment: the severity associated with a false positive result using the aptima hpv assay is serious.To mitigate this risk, hologic identified potentially impacted specimens and informed the customer.Customer retested the samples in question.The potential impact to a patient who receives a false positive result for hpv would be inconvenience, anxiety, and over-testing.If the false positive result was obtained during repeat co-testing, a colposcopy is recommended.False positive gc or ct results from the ac2 assay and false positive t.Vaginalis results from the atv assay could lead to antibiotic overtreatment as well as adverse psychosocial outcomes for the patient and his/her partner(s).Customer retested the samples in question.Per the respective package inserts (aptima hpv assay: aw-12820, rev.004; ac2 assay: 501798, rev.008; atv assay: 502246, rev.006), the results from these assays should be interpreted in conjunction with other laboratory and clinical data available for the clinician.
 
Manufacturer Narrative
Final mdr: field service engineer went to the customer site, repaired the instrument, and confirmed that the tigris instrument was correctly functioning.The cause of the failure is the auto detect (ad) injector.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TIGRIS INSTRUMENT SYS-CD
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
HOLOGIC INCORPORATED
10210 genetic center drive
san diego 92121
MDR Report Key12411479
MDR Text Key280606676
Report Number2024800-2021-00007
Device Sequence Number1
Product Code MKZ
Combination Product (y/n)N
PMA/PMN Number
K003395
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial
Report Date 09/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue Number105118
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/01/2021
Patient Sequence Number1
Patient Outcome(s) Other;
-
-